ISDS Case Map
medicines
The Australian Medical Association (AMA) wants assurances that a Trans Pacific Partnership (TPP) deal will not push up medicine prices.
Australian Trade Minister Andrew Robb lashed out at consumer groups and the Greens for spreading misinformation about the Trans-Pacific Partnership, before walking into a meeting with 11 trade counterparts in Sydney on Saturday to finalise the "basic elements" of the deal.
Many critics are pointing out that the lack of an Ebola vaccine is due to the intellectual property protections offered through trade deals like the Transatlantic Trade and Investment Partnership.
Social organizations defending the interests of health patients have spoken out against the TPP.
Brand name pharmaceutical companies are advocating for inclusion of disciplines on public pharmaceutical reimbursement programs in the ongoing negotiations of the Trans-Pacific Partnership and the Transatlantic Trade and Investment Partnership.
How the European trade agenda continues to undermine access to medicines
Danish companies -- such as pharmaceutical giant Novo-Nordisk, who will get expanded patent protection in Canada -- see huge opportunities for boosting their revenues through CETA.
The inclusion of intellectual property in the ongoing negotiations of the Regional Comprehensive Economic Partnership between 16 countries, most of them Asian, is raising concerns about “TRIPS-plus” measures that could jeopardise generic drugs production in India, according to Médecins Sans Frontières.
A leaked copy of the full text of the Canada-EU free trade agreement was posted online late Wednesday and appeared to confirm the fears of the deal’s critics on both sides of the Atlantic.
The Australian Medical Association (AMA) has urged the Australian government to reject provisions in the Trans Pacific Partnership agreement (TPP) that “could undermine the Pharmaceutical Benefits Scheme and compromise the ability of governments to improve public health”.
